{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:51:22Z","timestamp":1781941882722,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04623-x","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:32:47Z","timestamp":1781940767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic utility of novel marker TRIM63 ISH in the workup of uterine perivascular epithelioid cell tumors"],"prefix":"10.1007","author":[{"given":"Phoebe M.","family":"Hammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri","family":"Longacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke E.","family":"Howitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur R.","family":"Sangoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"issue":"10","key":"4623_CR1","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1097\/PAS.0000000000001119","volume":"42","author":"JA Bennett","year":"2018","unstructured":"Bennett JA, Braga AC, Pinto A, Van de Vijver K, Cornejo K, Pesci A et al (2018) Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors. Am J Surg Pathol 42(10):1370\u20131383","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4623_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/gcc.22908","volume":"60","author":"JA Bennett","year":"2021","unstructured":"Bennett JA, Oliva E (2021) Perivascular epithelioid cell tumors (PEComa) of the gynecologic tract. Genes Chromosomes Cancer 60(3):168\u2013179","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"4623_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/PAS.0000000000000133","volume":"38","author":"JK Schoolmeester","year":"2014","unstructured":"Schoolmeester JK, Howitt BE, Hirsch MS, Dal Cin P, Quade BJ, Nucci MR (2014) Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases. Am J Surg Pathol 38(2):176\u2013188","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4623_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/PAS.0000000000001572","volume":"45","author":"P Selenica","year":"2021","unstructured":"Selenica P, Conlon N, Gonzalez C, Frosina D, Jungbluth AA, Beets-Tan RGH et al (2021) Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation. Am J Surg Pathol 45(1):77\u201392","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"4623_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00000478-200402000-00013","volume":"28","author":"EG Silva","year":"2004","unstructured":"Silva EG, Deavers MT, Bodurka DC, Malpica A (2004) Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa. Am J Surg Pathol 28(2):244\u2013249","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4623_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/01.pas.0000213346.57391.70","volume":"31","author":"KW Simpson","year":"2007","unstructured":"Simpson KW, Albores-Saavedra J (2007) HMB-45 reactivity in conventional uterine leiomyosarcomas. Am J Surg Pathol 31(1):95\u201398","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"4623_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/PGP.0000000000000653","volume":"39","author":"A Valencia-Guerrero","year":"2020","unstructured":"Valencia-Guerrero A, Pinto A, Anderson WJ, Trevisan G, Nucci MR, Hirsch MS (2020) PNL2: A Useful Adjunct Biomarker to HMB45 in the Diagnosis of Uterine Perivascular Epithelioid Cell Tumor (PEComa). Int J Gynecol Pathol 39(6):529\u2013536","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"4623_CR8","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.humpath.2006.01.008","volume":"37","author":"CC Pan","year":"2006","unstructured":"Pan CC, Jong YJ, Chai CY, Huang SH, Chen YJ (2006) Comparative genomic hybridization study of perivascular epithelioid cell tumor: molecular genetic evidence of perivascular epithelioid cell tumor as a distinctive neoplasm. Hum Pathol 37(5):606\u2013612","journal-title":"Hum Pathol"},{"issue":"3","key":"4623_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/path.2289","volume":"214","author":"CC Pan","year":"2008","unstructured":"Pan CC, Chung MY, Ng KF, Liu CY, Wang JS, Chai CY et al (2008) Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma. J Pathol 214(3):387\u2013393","journal-title":"J Pathol"},{"issue":"5","key":"4623_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/PAS.0b013e31824a8a37","volume":"36","author":"I Malinowska","year":"2012","unstructured":"Malinowska I, Kwiatkowski DJ, Weiss S, Martignoni G, Netto G, Argani P (2012) Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction. Am J Surg Pathol 36(5):783\u2013784","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4623_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/PAS.0000000000000349","volume":"39","author":"JK Schoolmeester","year":"2015","unstructured":"Schoolmeester JK, Dao LN, Sukov WR, Wang L, Park KJ, Murali R et al (2015) TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis. Am J Surg Pathol 39(3):394\u2013404","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"4623_CR12","doi-asserted-by":"publisher","first-page":"e692","DOI":"10.1016\/j.clgc.2020.04.004","volume":"18","author":"M Vannucchi","year":"2020","unstructured":"Vannucchi M, Minervini A, Salvi M, Montironi R, Raspollini MR (2020) TFE3 Gene Rearrangement in Perivascular Epithelioid Cell Neoplasm (PEComa) of the Genitourinary Tract. Clin Genitourin Cancer 18(6):e692\u2013e7","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"4623_CR13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/PAS.0000000000000389","volume":"39","author":"NP Agaram","year":"2015","unstructured":"Agaram NP, Sung YS, Zhang L, Chen CL, Chen HW, Singer S et al (2015) Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications. Am J Surg Pathol 39(6):813\u2013825","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"4623_CR14","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/s41379-021-00803-z","volume":"34","author":"XM Wang","year":"2021","unstructured":"Wang XM, Zhang Y, Mannan R, Skala SL, Rangaswamy R, Chinnaiyan A et al (2021) TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma. Mod Pathol 34(8):1596\u20131607","journal-title":"Mod Pathol"},{"key":"4623_CR15","doi-asserted-by":"publisher","first-page":"105862","DOI":"10.1016\/j.humpath.2025.105862","volume":"161","author":"HJ Lee","year":"2025","unstructured":"Lee HJ, Shokri F, Tretiakova MS (2025) Diagnostic accuracy of TRIM63 RNA-ISH in MiTF-rearranged renal cell carcinomas: Results from a 331-tumor validation cohort. Hum Pathol 161:105862","journal-title":"Hum Pathol"},{"issue":"3","key":"4623_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12032-024-02305-9","volume":"41","author":"AS Taylor","year":"2024","unstructured":"Taylor AS, Mannan R, Pantanowitz L, Chinnaiyan AM, Dhanasekaran SM, Hrycaj S et al (2024) Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS). Med Oncol 41(3):76","journal-title":"Med Oncol"},{"key":"4623_CR17","doi-asserted-by":"crossref","unstructured":"Sangoi AR, Lobo A, Jha S, Kaushal S, Tiwari A, Mubeen A et al (2025) Renal epithelioid angiomyolipoma: prognostic implications of targeted immunohistochemical and molecular markers in conjunction with clinicopathologic features. Am J Surg Pathol 49(8):781\u2013788","DOI":"10.1097\/PAS.0000000000002411"},{"key":"4623_CR18","doi-asserted-by":"crossref","unstructured":"Sangoi AR, Lobo A, Tiwari A, Akgul M, Kandukuri S, Acosta AM et al (2025) Perivascular epithelioid cell tumors of the urinary bladder: a multi-institutional clinicopathologic and molecular analysis of 21 cases. Virchows Arch","DOI":"10.1007\/s00428-025-04250-y"},{"issue":"7","key":"4623_CR19","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1158\/2767-9764.CRC-23-0139","volume":"3","author":"S Testa","year":"2023","unstructured":"Testa S, Bui NQ, Ganjoo KN (2023) Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis. Cancer Res Commun 3(7):1212\u20131223","journal-title":"Cancer Res Commun"},{"issue":"12","key":"4623_CR20","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1097\/01.pas.0000173232.22117.37","volume":"29","author":"AL Folpe","year":"2005","unstructured":"Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW (2005) Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol 29(12):1558\u20131575","journal-title":"Am J Surg Pathol"},{"key":"4623_CR21","volume-title":"WHO Classification of Female Genital Tumors","author":"WHO Classification of Tumors Editorial Board","year":"2020","unstructured":"WHO Classification of Tumors Editorial Board (2020) WHO Classification of Female Genital Tumors, 5 edn. International Agency for Research on Cancer, Lyon, France","edition":"5"},{"issue":"6","key":"4623_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/PGP.0000000000000841","volume":"41","author":"KA Devereaux","year":"2022","unstructured":"Devereaux KA, Steiner DF, Ho C, Gomez AJ, Gilks B, Longacre TA et al (2022) A Multiplex SNaPshot Assay is a Rapid and Cost-Effective Method for Detecting POLE Exonuclease Domain Mutations in Endometrial Carcinoma. Int J Gynecol Pathol 41(6):541\u2013551","journal-title":"Int J Gynecol Pathol"},{"key":"4623_CR23","doi-asserted-by":"crossref","unstructured":"Nohr E, Kunder CA, Jones C, Sutton S, Fung E, Zhu H et al (2019) Development and clinical validation of a targeted RNAseq panel (Fusion-STAMP) for diagnostic and predictive gene fusion detection in solid tumors. bioRxiv 870634","DOI":"10.1101\/870634"},{"issue":"9","key":"4623_CR24","doi-asserted-by":"publisher","first-page":"e0237802","DOI":"10.1371\/journal.pone.0237802","volume":"15","author":"R Woodhouse","year":"2020","unstructured":"Woodhouse R, Li M, Hughes J, Delfosse D, Skoletsky J, Ma P et al (2020) Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin. PLoS ONE 15(9):e0237802","journal-title":"PLoS ONE"},{"issue":"24","key":"4623_CR25","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.18632\/oncotarget.26797","volume":"10","author":"N Beaubier","year":"2019","unstructured":"Beaubier N, Tell R, Lau D, Parsons JR, Bush S, Perera J et al (2019) Clinical validation of the tempus xT next-generation targeted oncology sequencing assay. Oncotarget 10(24):2384\u20132396","journal-title":"Oncotarget"},{"key":"4623_CR26","unstructured":"Complete Tuberous Sclerosis Sequencing and CNV Evaluation [Internet] (2023) Athena Diagnostics. [Cited 2026 Jan 19]. Available from: https:\/\/www.athenadiagnostics.com\/view-full-catalog\/complete-tuberous-sclerosis-sequencing-and-cnv-evaluation"},{"issue":"2","key":"4623_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/PAS.0000000000002334","volume":"49","author":"A Agaimy","year":"2025","unstructured":"Agaimy A, Michal M, Abdelsatir A, Abdelsatir AA, Abdulrahim S, Laco J et al (2025) TFE3 -rearranged Head and Neck Neoplasms: Twenty-two Cases Spanning the Morphologic Continuum Between Alveolar Soft Part Sarcoma and PEComa and Highlighting Genotypic Diversity. Am J Surg Pathol 49(2):104\u2013112","journal-title":"Am J Surg Pathol"},{"key":"4623_CR28","doi-asserted-by":"publisher","first-page":"550506","DOI":"10.3389\/fphys.2020.550506","volume":"11","author":"C Pablo Tortola","year":"2020","unstructured":"Pablo Tortola C, Fielitz B, Li Y, R\u00fcdebusch J, Luft FC, Fielitz J (2020) Activation of Tripartite Motif Containing 63 Expression by Transcription Factor EB and Transcription Factor Binding to Immunoglobulin Heavy Chain Enhancer 3 Is Regulated by Protein Kinase D and Class IIa Histone Deacetylases. Front Physiol 11:550506","journal-title":"Front Physiol"},{"key":"4623_CR29","doi-asserted-by":"crossref","unstructured":"Mannan R, Chen YB, Wang X, Zhang Y, Hosseini N, Sangoi AR et al (2025) TRIM63 overexpression in FISH-negative MiTF family altered renal cell carcinoma (MiTF RCC). Mod Pathol 100873","DOI":"10.1016\/j.modpat.2025.100873"},{"issue":"7","key":"4623_CR30","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/PAS.0000000000002218","volume":"48","author":"P Argani","year":"2024","unstructured":"Argani P, Gross JM, Baraban E, Rooper LM, Chen S, Lin MT et al (2024) TFE3 -Rearranged PEComa\/PEComa-like Neoplasms: Report of 25 New Cases Expanding the Clinicopathologic Spectrum and Highlighting its Association With Prior Exposure to Chemotherapy. Am J Surg Pathol 48(7):777\u2013789","journal-title":"Am J Surg Pathol"},{"issue":"33","key":"4623_CR31","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1200\/JCO.21.01728","volume":"39","author":"AJ Wagner","year":"2021","unstructured":"Wagner AJ, Ravi V, Riedel RF, Ganjoo K, Van Tine BA, Chugh R et al (2021) -Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors. J Clin Oncol 39(33):3660\u20133670","journal-title":"J Clin Oncol"},{"issue":"13","key":"4623_CR32","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1200\/JCO.23.02266","volume":"42","author":"AJ Wagner","year":"2024","unstructured":"Wagner AJ, Ravi V, Riedel RF, Ganjoo K, Van Tine BA, Chugh R et al (2024) Phase II Trial of. J Clin Oncol 42(13):1472\u20131476","journal-title":"J Clin Oncol"},{"issue":"1","key":"4623_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/his.15560","volume":"88","author":"P Argani","year":"2026","unstructured":"Argani P (2026) MiT family translocation carcinomas of the kidney and related entities. Histopathology 88(1):193\u2013213","journal-title":"Histopathology"},{"issue":"7826","key":"4623_CR34","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-020-2444-0","volume":"585","author":"G Napolitano","year":"2020","unstructured":"Napolitano G, Di Malta C, Esposito A, de Araujo MEG, Pece S, Bertalot G et al (2020) A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dub\u00e9 syndrome. Nature 585(7826):597\u2013602","journal-title":"Nature"},{"issue":"12","key":"4623_CR35","doi-asserted-by":"publisher","first-page":"e15793","DOI":"10.1371\/journal.pone.0015793","volume":"5","author":"SB Hong","year":"2010","unstructured":"Hong SB, Oh H, Valera VA, Baba M, Schmidt LS, Linehan WM (2010) Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS ONE 5(12):e15793","journal-title":"PLoS ONE"},{"issue":"1","key":"4623_CR36","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1038\/s41467-022-34617-7","volume":"13","author":"K Asrani","year":"2022","unstructured":"Asrani K, Woo J, Mendes AA, Schaffer E, Vidotto T, Villanueva CR et al (2022) An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-Rag activation in renal cells with TSC2 loss. Nat Commun 13(1):6808","journal-title":"Nat Commun"},{"issue":"5","key":"4623_CR37","doi-asserted-by":"publisher","first-page":"e16877","DOI":"10.15252\/emmm.202216877","volume":"15","author":"C Di Malta","year":"2023","unstructured":"Di Malta C, Zampelli A, Granieri L, Vilardo C, De Cegli R, Cinque L et al (2023) TFEB and TFE3 drive kidney cystogenesis and tumorigenesis. EMBO Mol Med 15(5):e16877","journal-title":"EMBO Mol Med"},{"issue":"1","key":"4623_CR38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41467-023-44229-4","volume":"15","author":"N Alesi","year":"2024","unstructured":"Alesi N, Khabibullin D, Rosenthal DM, Akl EW, Cory PM, Alchoueiry M et al (2024) TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex. Nat Commun 15(1):406","journal-title":"Nat Commun"},{"issue":"1","key":"4623_CR39","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1038\/s41467-021-24499-6","volume":"12","author":"N Alesi","year":"2021","unstructured":"Alesi N, Akl EW, Khabibullin D, Liu HJ, Nidhiry AS, Garner ER et al (2021) TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism. Nat Commun 12(1):4245","journal-title":"Nat Commun"},{"issue":"6","key":"4623_CR40","doi-asserted-by":"publisher","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","volume":"307","author":"SC Bodine","year":"2014","unstructured":"Bodine SC, Baehr LM (2014) Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1. Am J Physiol Endocrinol Metab 307(6):E469\u2013E484","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4623_CR41","doi-asserted-by":"crossref","unstructured":"Dinh A, Hirsch M, Nucci M, Gilks CB, Kinloch M, Baniak N (2025) 974 utilization of TRIM63 in the distinction of gynecologic PEComas from leiomyomas and leiomyosarcomas. Lab Invest 105(3)","DOI":"10.1016\/j.labinv.2024.103208"},{"issue":"12","key":"4623_CR42","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1159\/000510241","volume":"98","author":"S Akumalla","year":"2020","unstructured":"Akumalla S, Madison R, Lin DI, Schrock AB, Yakirevich E, Rosenzweig M et al (2020) Characterization of Clinical Cases of Malignant PEComa via Comprehensive Genomic Profiling of DNA and RNA. Oncology 98(12):905\u2013912","journal-title":"Oncology"},{"issue":"4","key":"4623_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41379-021-00855-1","volume":"35","author":"JA Bennett","year":"2022","unstructured":"Bennett JA, Ordulu Z, Pinto A, Wanjari P, Antonescu CR, Ritterhouse LL et al (2022) Uterine PEComas: correlation between melanocytic marker expression and TSC alterations\/TFE3 fusions. Mod Pathol 35(4):515\u2013523","journal-title":"Mod Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04623-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04623-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04623-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:32:50Z","timestamp":1781940770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04623-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":43,"alternative-id":["4623"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04623-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Samples were used in accordance with ethical guidelines for the use of retrospective tissue samples at our institution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical responsibilities of authors section and compliance with ethical rules"}},{"value":"The authors have no financial or non-financial conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}